1
|
Filippova TA, Masamrekh RA, Shumyantseva VV, Latsis IA, Farafonova TE, Ilina IY, Kanashenko SL, Moshkovskii SA, Kuzikov AV. Electrochemical biosensor for trypsin activity assay based on cleavage of immobilized tyrosine-containing peptide. Talanta 2023; 257:124341. [PMID: 36821964 DOI: 10.1016/j.talanta.2023.124341] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2022] [Revised: 01/13/2023] [Accepted: 02/09/2023] [Indexed: 02/16/2023]
Abstract
In this work, we proposed a biosensor for trypsin proteolytic activity assay using immobilization of model peptides on screen-printed electrodes (SPE) modified with gold nanoparticles (AuNPs) prepared by electrosynthetic method. Sensing of proteolytic activity was based on electrochemical oxidation of tyrosine residues of peptides. We designed peptides containing N-terminal cysteine residue for immobilization on an SPE, modified with gold nanoparticles, trypsin-specific cleavage site and tyrosine residue as a redox label. The peptides were immobilized on SPE by formation of chemical bonds between mercapto groups of the N-terminal cysteine residues and AuNPs. After the incubation with trypsin, time-dependent cleavage of the immobilized peptides was observed by decline in tyrosine electrochemical oxidation signal. The kinetic parameters of trypsin, such as the catalytic constant (kcat), the Michaelis constant (KM) and the catalytic efficiency (kcat/KM), toward the CGGGRYR peptide were determined as 0.33 ± 0.01 min-1, 198 ± 24 nM and 0.0016 min-1 nM-1, respectively. Using the developed biosensor, we demonstrated the possibility of analysis of trypsin specificity toward the peptides with amino acid residues disrupting proteolysis. Further, we designed the peptides with proline or glutamic acid residues after the cleavage site (CGGRPYR and CGGREYR), and trypsin had reduced activity toward both of them according to the existing knowledge of the enzyme specificity. The developed biosensor system allows one to perform a comparative analysis of the protease steady-state kinetic parameters and specificity toward model peptides with different amino acid sequences.
Collapse
Affiliation(s)
- Tatiana A Filippova
- Pirogov Russian National Research Medical University, 1 Ostrovityanova st., Moscow 117997, Russia; Institute of Biomedical Chemistry, 10, Pogodinskaya st., Moscow, 119121, Russia
| | - Rami A Masamrekh
- Pirogov Russian National Research Medical University, 1 Ostrovityanova st., Moscow 117997, Russia; Institute of Biomedical Chemistry, 10, Pogodinskaya st., Moscow, 119121, Russia
| | - Victoria V Shumyantseva
- Pirogov Russian National Research Medical University, 1 Ostrovityanova st., Moscow 117997, Russia; Institute of Biomedical Chemistry, 10, Pogodinskaya st., Moscow, 119121, Russia
| | - Ivan A Latsis
- Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya st., Moscow, 119435, Russia
| | | | - Irina Y Ilina
- Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya st., Moscow, 119435, Russia
| | - Sergey L Kanashenko
- Institute of Biomedical Chemistry, 10, Pogodinskaya st., Moscow, 119121, Russia
| | - Sergei A Moshkovskii
- Pirogov Russian National Research Medical University, 1 Ostrovityanova st., Moscow 117997, Russia; Federal Research and Clinical Center of Physical-Chemical Medicine, 1a Malaya Pirogovskaya st., Moscow, 119435, Russia.
| | - Alexey V Kuzikov
- Pirogov Russian National Research Medical University, 1 Ostrovityanova st., Moscow 117997, Russia; Institute of Biomedical Chemistry, 10, Pogodinskaya st., Moscow, 119121, Russia.
| |
Collapse
|
3
|
Gutiérrez OA, Chavez M, Lissi E. A theoretical approach to some analytical properties of heterogeneous enzymatic assays. Anal Chem 2005; 76:2664-8. [PMID: 15117213 DOI: 10.1021/ac049885d] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Heterogeneous enzymatic assays (HEA), where an enzyme in solution acts upon an immobilized substrate, are been increasingly used. Given their high throughput and versatility they hold great potential for developing massive enzyme inhibitor screening. However, current HEA lack, in general, rigorous quantitative use. This is in part due to technical problems as a multiplicity of suboptimal substrate populations achieved with traditional immobilization techniques but, more importantly, is due to a poor understanding of the particular kinetic behavior of these systems. This paper addresses the kinetic features of HEA that arise from the very low amount of solid-phase substrate and the resulting inalterability of the free enzyme concentration during the assay, which classify HEA as enzyme quasi-saturable systems (EQSS). We assessed the optimal enzyme concentration working range and time of reaction. We also considered certain attributes of HEA for evaluating isosteric inhibitors. These studies were done on the basis of a simplified model for the kinetics of EQSS and a formal splitting of the functional factor of the analytical sensitivity of an enzymatic assay into [E(o)]/K(m)-dependent and temporal components.
Collapse
Affiliation(s)
- O A Gutiérrez
- Centro de Estudio de las Proteinas, Facultad de Biología, Universidad de la Habana, 25 # 455 entre J e I. CP 10 400, Vedado, Ciudad de la Habana, Cuba.
| | | | | |
Collapse
|
4
|
Fournout S, Roquet F, Salhi SL, Seyer R, Valverde V, Masson JM, Jouin P, Pau B, Nicolas M, Hanin V. Development and standardization of an immuno-quantified solid phase assay for HIV-1 aspartyl protease activity and its application to the evaluation of inhibitors. Anal Chem 1997; 69:1746-52. [PMID: 9145028 DOI: 10.1021/ac961075h] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The catELISA technique was modified and standardized for measuring HIV-1 aspartyl protease activity and evaluating the potency of synthetic peptide inhibitors. This immuno-quantified solid phase assay combines the use of an immobilized C-terminal biotinylated peptide as substrate, a crude enzyme preparation, and a highly specific antiserum elicited against the C-terminal product of the enzyme reaction. A standard curve of this C-terminal product was constructed to determine the enzyme activity. This assay, which requires less enzyme and substrate, is more sensitive than the conventional HPLC method. The amounts of C-terminal peptide produced in solution as determined from ELISA and HPLC standard curves were comparable. Analogues of peptidomimetics designed in our laboratory were assayed for their potency to inhibit the enzyme. One of them, H4, which is a hydroxyethylamine isostere of the Phe-Pro peptide bond, was a powerful inhibitor.
Collapse
Affiliation(s)
- S Fournout
- Laboratoire d'Immunoanalyse et Innovation en Biologie Clinique, CNRS UMR 9921, Faculte de Pharmacie, Montpellier, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Yu SL, Wang N, Liou CY, Syu WJ. Assay of HIV-1 protease activity by use of crude preparations of enzyme and biotinylated substrate. J Virol Methods 1995; 53:63-73. [PMID: 7635927 DOI: 10.1016/0166-0934(94)00177-i] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
An enzyme immunoassay was developed for monitoring protease reactions of human immunodeficiency virus (HIV). The protease and its substrate, the gag precursor, were generated separately in Escherichia coli. The HIV-1 protease was generated with a glutathione-S-transferase expression system and the gag substrate, named Pin17/24, was prepared with a PinPoint expression system. Pin17/24 consists of an N-terminal peptide, which is biotinylated in E. coli, fused with a C-terminal peptide that contains a protease cleavage site flanked by p17 and p24 segments. Through its biotin in the N-terminal region, Pin17/24 bound to ELISA plates coated with avidin, whereas through its C-terminal region, the same molecule of Pin17/24 could be recognized by an anti-p24 monoclonal antibody. When the protease was added to Pin17/24, the p24 fragment was released from the biotinylated fusion protein and could no longer be retained on the avidin plates, and as a result, binding of the anti-p24 monoclonal antibody decreased. The binding was specific and the reaction was inhibited by a known HIV protease inhibitor. Due to the specific interactions between avidin and biotin, monoclonal antibody and antigen, and the HIV protease and the gag substrate, crude preparations of these reagents can be used readily in the assay. The simplicity and feasibility of this method should be useful for simultaneous monitoring of many enzyme reactions, particularly for screening possible HIV protease inhibitors.
Collapse
Affiliation(s)
- S L Yu
- Graduate Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan, ROC
| | | | | | | |
Collapse
|